Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

Clinical trial NCT07264075 · RECRUITING

Trial details

NCT number

NCT07264075

Sponsor

Groupe Oncologie Radiotherapie Tete et Cou

Status

RECRUITING

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2026-05-05

Primary completion

2030-05-01

Enrollment

780

View on ClinicalTrials.gov